Position in BBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$71,464,527
-$32,769,926 QoQ
Shares Held
959,513
-31.6% QoQ
Ownership
0.491%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. BBIO ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,464,527 | 959,513 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $104,234,453 | 1,403,642 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $103,013,210 | 1,346,754 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $72,841,121 | 1,402,409 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $58,883,830 | 1,363,683 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $44,486,297 | 1,286,847 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $36,310,197 | 1,323,258 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $32,571,053 | 1,279,303 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $28,598,049 | 1,129,019 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $34,915,140 | 1,129,209 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $46,626,217 | 1,154,972 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,428,736 | 1,153,915 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,423,477 | 1,129,272 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,872,977 | 957,357 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,171,698 | 941,168 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,304,216 | 936,038 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,776,281 | 966,551 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,122,491 | 997,290 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,876,288 | 1,011,768 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $52,278,749 | 1,115,399 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $65,718,719 | 1,078,063 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $63,387,014 | 1,029,010 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $59,222,966 | 832,836 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $31,987,298 | 852,540 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,776,149 | 790,437 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $22,677,478 | 781,982 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||